NRC Approves $20M Stock Repurchase Program
Ticker: NRC · Form: 8-K · Filed: May 13, 2024 · CIK: 70487
| Field | Detail |
|---|---|
| Company | National Research CORP (NRC) |
| Form Type | 8-K |
| Filed Date | May 13, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | bullish |
Sentiment: bullish
Topics: stock-repurchase, shareholder-return
TL;DR
NRC just authorized a $20M buyback, good for 2 years.
AI Summary
National Research Corporation (NRC) announced on May 8, 2024, that its Board of Directors approved a new stock repurchase program. The company is authorized to repurchase up to $20 million of its common stock through May 8, 2026.
Why It Matters
This indicates management's confidence in the company's valuation and a commitment to returning capital to shareholders.
Risk Assessment
Risk Level: low — The filing is a routine announcement of a stock repurchase program, which is generally considered a positive or neutral event.
Key Numbers
- $20.0M — Stock Repurchase Authorization (The maximum amount the company can spend on repurchasing its own shares.)
Key Players & Entities
- National Research Corporation (company) — Registrant
- $20 million (dollar_amount) — Stock repurchase authorization
- May 8, 2024 (date) — Date of Board approval
- May 8, 2026 (date) — Expiration date of repurchase program
FAQ
What is the total amount authorized for the stock repurchase program?
The company is authorized to repurchase up to $20 million of its common stock.
When was the stock repurchase program approved?
The Board of Directors approved the program on May 8, 2024.
What is the expiration date of the stock repurchase program?
The program is authorized to continue through May 8, 2026.
What is the ticker symbol for National Research Corporation?
The filing does not explicitly state the ticker symbol, but the company is National Research Corporation.
What is the primary business of National Research Corporation?
National Research Corporation is in the business of Commercial Physical & Biological Research, SIC code 8731.
Filing Stats: 775 words · 3 min read · ~3 pages · Grade level 12.3 · Accepted 2024-05-13 15:20:39
Key Financial Figures
- $0.001 — of each exchange on which registered $0.001 Par Value Common Stock NRC The NASDAQ
Filing Documents
- nrc20240510_8k.htm (8-K) — 48KB
- 0001437749-24-016208.txt ( ) — 174KB
- nrc-20240508.xsd (EX-101.SCH) — 3KB
- nrc-20240508_def.xml (EX-101.DEF) — 11KB
- nrc-20240508_lab.xml (EX-101.LAB) — 14KB
- nrc-20240508_pre.xml (EX-101.PRE) — 11KB
- nrc20240510_8k_htm.xml (XML) — 3KB
07
Item 5.07 Submission of Matters to a Vote of Security Holders. On May 8, 2024, National Research Corporation, a Delaware corporation (the "Company"), held its 2024 annual meeting of shareholders (the "Annual Meeting"). At the Annual Meeting, the Company's shareholders voted on the following proposals: The election of two directors, Michael D. Hays and John N. Nunnelly, to the Board for a three-year term to expire at the Company's 2027 annual meeting of shareholders; The ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for 2024; and An advisory vote to approve the compensation of the Company's named executive officers as disclosed in the Company's proxy statement relating to the Annual Meeting As of the March 20, 2024, the record date for the determination of the shareholders entitled to notice of, and to vote at, the Annual Meeting, 23,871,543 shares of the Company's common stock were outstanding and eligible to vote. Approximately 96% of all shares (and votes) were represented at the Annual Meeting or by proxy. The following are the final votes on the matters presented for shareholder consideration at the Annual Meeting: Election of Directors The shareholders elected Michael D. Hays and John N. Nunnelly as directors for three-year terms to expire at the Company's 2027 annual meeting of shareholders. The results of the vote were as follows: For Against Abstain Broker Non-Votes Name Votes Percentage (1) Votes Percentage (1) Votes Percentage (2) Votes Percentage (2) Michael D. Hays 21,614,892 97.12% 640,441 2.87% 29,044 N/A 582,200 N/A John N. Nunnelly 20,297,568 91.20% 1,957,765 8.79% 29,044 N/A 582,200 N/A Ratify Appointment of KPMG LLP for 2024 The shareholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for 2024. The results of the vote were as follows: For Against Abstain Broker Non-Vote